The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars

Frontiers in Psychology 12 (2021)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,654

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Equipoise and Nonmedical Risks.Brandon Boesch - 2014 - American Journal of Bioethics 14 (4):16-18.
The Case for Disclosure of Biologics Manufacturing Information.Yaniv Heled - 2019 - Journal of Law, Medicine and Ethics 47 (S4):54-78.
Prudent Precaution in Clinical Trials of Nanomedicines.Gary E. Marchant & Rachel A. Lindor - 2012 - Journal of Law, Medicine and Ethics 40 (4):831-840.
Health risks and the health care professional.Helen L. Treanor - 2000 - Medicine, Health Care and Philosophy 3 (3):251-254.

Analytics

Added to PP
2021-01-27

Downloads
6 (#1,467,817)

6 months
5 (#649,144)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations